Home/Filings/4/0001613103-24-000008
4//SEC Filing

Salmon Sean 4

Accession 0001613103-24-000008

CIK 0001613103other

Filed

Feb 22, 7:00 PM ET

Accepted

Feb 23, 5:18 PM ET

Size

18.7 KB

Accession

0001613103-24-000008

Insider Transaction Report

Form 4
Period: 2024-02-21
Salmon Sean
EVP & Group President Diabetes
Transactions
  • Sale

    Ordinary Shares

    2024-02-21$85.06/sh1,594$135,58677,390 total
  • Sale

    Ordinary Shares

    2024-02-21$85.15/sh13,066$1,112,57064,324 total
  • Sale

    Ordinary Shares

    2024-02-21$85.12/sh16,035$1,364,89948,289 total
  • Exercise/Conversion

    Stock Option (Right to Buy)

    2024-02-211,59413,066 total
    Exercise: $62.76From: 2015-07-28Exp: 2024-07-28Ordinary Shares (1,594 underlying)
  • Exercise/Conversion

    Ordinary Shares

    2024-02-21$62.76/sh+13,066$820,02262,949 total
  • Exercise/Conversion

    Ordinary Shares

    2024-02-21$62.76/sh+1,594$100,03949,833 total
  • Exercise/Conversion

    Ordinary Shares

    2024-02-21$74.84/sh+16,035$1,200,05978,984 total
  • Exercise/Conversion

    Stock Option (Right to Buy)

    2024-02-2116,0350 total
    Exercise: $74.84From: 2016-01-27Exp: 2025-01-27Ordinary Shares (16,035 underlying)
  • Exercise/Conversion

    Stock Option (Right to Buy)

    2024-02-2113,0660 total
    Exercise: $62.76From: 2015-07-28Exp: 2024-07-28Ordinary Shares (13,066 underlying)
Footnotes (3)
  • [F1]Includes 186 units acquired through dividend reinvestment since the last report filed by the reporting person.
  • [F2]The price reported is a weighted average sale price for multiple transactions. The actual sales prices for the transactions ranged from $85.15 to $85.18. Full information regarding the number of shares purchased at each separate price will be provided to the Securities and Exchange Commission, the issuer or a security holder upon request.
  • [F3]The price reported is a weighted average sale price for multiple transactions. The actual sales prices for the transactions ranged from $85.12 to $85.14. Full information regarding the number of shares purchased at each separate price will be provided to the Securities and Exchange Commission, the issuer or a security holder upon request.

Issuer

Medtronic plc

CIK 0001613103

Entity typeother

Related Parties

1
  • filerCIK 0001792380

Filing Metadata

Form type
4
Filed
Feb 22, 7:00 PM ET
Accepted
Feb 23, 5:18 PM ET
Size
18.7 KB